In a subcutaneous EMT6 model of breast cancer, CD26 inhibition also slowed tumour growth, but here no increase in T-cell influx was detected, rather an increased recruitment of eosinophils to the tumours was essential for Sitagliptin mediated control of tumour growth [46]. Here, DPP4 is linked to breast carcinoma.